 | • レポートコード：QYR2104Z4301 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、口腔がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、化学療法）、用途別市場規模（口腔がん、歯肉がん、硬口蓋がん、頬内がん（頬粘膜がん）、唇がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・口腔がん治療の市場動向 ・企業の競争状況、市場シェア ・口腔がん治療の種類別市場規模（標的療法、化学療法） ・口腔がん治療の用途別市場規模（口腔がん、歯肉がん、硬口蓋がん、頬内がん（頬粘膜がん）、唇がん、その他） ・口腔がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・口腔がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・口腔がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・口腔がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・口腔がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca Plc、Bristol-Myers Squibb Co.、Eli Lilly and Co.、Endo International Plc、F. Hoffmann-La Roche Ltd.、Merck & Co., Inc.、Mylan NV、Pfizer Inc.、Sanofi、Teva Pharmaceutical Industries Ltd.） ・結論 |
Market Analysis and Insights: Global Oral Cancer Therapeutic Market
The global Oral Cancer Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Cancer Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Cancer Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Cancer Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Cancer Therapeutic market.
Global Oral Cancer Therapeutic Scope and Market Size
Oral Cancer Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Cancer Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Targeted Therapy
Chemotherapy
Segment by Application
Floor of Mouth Cancer
Gum Cancer
Hard Palate Cancer
Inner Cheek Cancer (Buccal Mucosa Cancer)
Lip Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca Plc
Bristol-Myers Squibb Co.
Eli Lilly and Co.
Endo International Plc
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Mylan NV
Pfizer Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Cancer Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.3 Market by Application
1.3.1 Global Oral Cancer Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Floor of Mouth Cancer
1.3.3 Gum Cancer
1.3.4 Hard Palate Cancer
1.3.5 Inner Cheek Cancer (Buccal Mucosa Cancer)
1.3.6 Lip Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oral Cancer Therapeutic Market Perspective (2016-2027)
2.2 Oral Cancer Therapeutic Growth Trends by Regions
2.2.1 Oral Cancer Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Cancer Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Oral Cancer Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Oral Cancer Therapeutic Industry Dynamic
2.3.1 Oral Cancer Therapeutic Market Trends
2.3.2 Oral Cancer Therapeutic Market Drivers
2.3.3 Oral Cancer Therapeutic Market Challenges
2.3.4 Oral Cancer Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Cancer Therapeutic Players by Revenue
3.1.1 Global Top Oral Cancer Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Oral Cancer Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Oral Cancer Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Cancer Therapeutic Revenue
3.4 Global Oral Cancer Therapeutic Market Concentration Ratio
3.4.1 Global Oral Cancer Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Cancer Therapeutic Revenue in 2020
3.5 Oral Cancer Therapeutic Key Players Head office and Area Served
3.6 Key Players Oral Cancer Therapeutic Product Solution and Service
3.7 Date of Enter into Oral Cancer Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Cancer Therapeutic Breakdown Data by Type
4.1 Global Oral Cancer Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Oral Cancer Therapeutic Forecasted Market Size by Type (2022-2027)
5 Oral Cancer Therapeutic Breakdown Data by Application
5.1 Global Oral Cancer Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Oral Cancer Therapeutic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oral Cancer Therapeutic Market Size (2016-2027)
6.2 North America Oral Cancer Therapeutic Market Size by Type
6.2.1 North America Oral Cancer Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Oral Cancer Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Oral Cancer Therapeutic Market Size by Type (2016-2027)
6.3 North America Oral Cancer Therapeutic Market Size by Application
6.3.1 North America Oral Cancer Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Oral Cancer Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Oral Cancer Therapeutic Market Size by Application (2016-2027)
6.4 North America Oral Cancer Therapeutic Market Size by Country
6.4.1 North America Oral Cancer Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Oral Cancer Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Oral Cancer Therapeutic Market Size (2016-2027)
7.2 Europe Oral Cancer Therapeutic Market Size by Type
7.2.1 Europe Oral Cancer Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Oral Cancer Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Oral Cancer Therapeutic Market Size by Type (2016-2027)
7.3 Europe Oral Cancer Therapeutic Market Size by Application
7.3.1 Europe Oral Cancer Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Oral Cancer Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Oral Cancer Therapeutic Market Size by Application (2016-2027)
7.4 Europe Oral Cancer Therapeutic Market Size by Country
7.4.1 Europe Oral Cancer Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Oral Cancer Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oral Cancer Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Oral Cancer Therapeutic Market Size by Type
8.2.1 Asia-Pacific Oral Cancer Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Cancer Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Cancer Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Cancer Therapeutic Market Size by Application
8.3.1 Asia-Pacific Oral Cancer Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oral Cancer Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oral Cancer Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Oral Cancer Therapeutic Market Size by Region
8.4.1 Asia-Pacific Oral Cancer Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Cancer Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oral Cancer Therapeutic Market Size (2016-2027)
9.2 Latin America Oral Cancer Therapeutic Market Size by Type
9.2.1 Latin America Oral Cancer Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Oral Cancer Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Oral Cancer Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Oral Cancer Therapeutic Market Size by Application
9.3.1 Latin America Oral Cancer Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Oral Cancer Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Oral Cancer Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Oral Cancer Therapeutic Market Size by Country
9.4.1 Latin America Oral Cancer Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Oral Cancer Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Cancer Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Oral Cancer Therapeutic Market Size by Type
10.2.1 Middle East & Africa Oral Cancer Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Cancer Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Cancer Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Cancer Therapeutic Market Size by Application
10.3.1 Middle East & Africa Oral Cancer Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oral Cancer Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oral Cancer Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Oral Cancer Therapeutic Market Size by Country
10.4.1 Middle East & Africa Oral Cancer Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Cancer Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc Oral Cancer Therapeutic Introduction
11.1.4 AstraZeneca Plc Revenue in Oral Cancer Therapeutic Business (2016-2021)
11.1.5 AstraZeneca Plc Recent Development
11.2 Bristol-Myers Squibb Co.
11.2.1 Bristol-Myers Squibb Co. Company Details
11.2.2 Bristol-Myers Squibb Co. Business Overview
11.2.3 Bristol-Myers Squibb Co. Oral Cancer Therapeutic Introduction
11.2.4 Bristol-Myers Squibb Co. Revenue in Oral Cancer Therapeutic Business (2016-2021)
11.2.5 Bristol-Myers Squibb Co. Recent Development
11.3 Eli Lilly and Co.
11.3.1 Eli Lilly and Co. Company Details
11.3.2 Eli Lilly and Co. Business Overview
11.3.3 Eli Lilly and Co. Oral Cancer Therapeutic Introduction
11.3.4 Eli Lilly and Co. Revenue in Oral Cancer Therapeutic Business (2016-2021)
11.3.5 Eli Lilly and Co. Recent Development
11.4 Endo International Plc
11.4.1 Endo International Plc Company Details
11.4.2 Endo International Plc Business Overview
11.4.3 Endo International Plc Oral Cancer Therapeutic Introduction
11.4.4 Endo International Plc Revenue in Oral Cancer Therapeutic Business (2016-2021)
11.4.5 Endo International Plc Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Oral Cancer Therapeutic Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Oral Cancer Therapeutic Introduction
11.6.4 Merck & Co., Inc. Revenue in Oral Cancer Therapeutic Business (2016-2021)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Mylan NV
11.7.1 Mylan NV Company Details
11.7.2 Mylan NV Business Overview
11.7.3 Mylan NV Oral Cancer Therapeutic Introduction
11.7.4 Mylan NV Revenue in Oral Cancer Therapeutic Business (2016-2021)
11.7.5 Mylan NV Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Oral Cancer Therapeutic Introduction
11.8.4 Pfizer Inc. Revenue in Oral Cancer Therapeutic Business (2016-2021)
11.8.5 Pfizer Inc. Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Oral Cancer Therapeutic Introduction
11.9.4 Sanofi Revenue in Oral Cancer Therapeutic Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Details
11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Introduction
11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Oral Cancer Therapeutic Business (2016-2021)
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Oral Cancer Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Global Oral Cancer Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Oral Cancer Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oral Cancer Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Oral Cancer Therapeutic Market Share by Regions (2016-2021)
Table 8. Global Oral Cancer Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Oral Cancer Therapeutic Market Share by Regions (2022-2027)
Table 10. Oral Cancer Therapeutic Market Trends
Table 11. Oral Cancer Therapeutic Market Drivers
Table 12. Oral Cancer Therapeutic Market Challenges
Table 13. Oral Cancer Therapeutic Market Restraints
Table 14. Global Oral Cancer Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Oral Cancer Therapeutic Market Share by Players (2016-2021)
Table 16. Global Top Oral Cancer Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Cancer Therapeutic as of 2020)
Table 17. Ranking of Global Top Oral Cancer Therapeutic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Oral Cancer Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oral Cancer Therapeutic Product Solution and Service
Table 21. Date of Enter into Oral Cancer Therapeutic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oral Cancer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Oral Cancer Therapeutic Revenue Market Share by Type (2016-2021)
Table 25. Global Oral Cancer Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Oral Cancer Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Oral Cancer Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Oral Cancer Therapeutic Revenue Market Share by Application (2016-2021)
Table 29. Global Oral Cancer Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Oral Cancer Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Oral Cancer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Oral Cancer Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Oral Cancer Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Oral Cancer Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Oral Cancer Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Oral Cancer Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Oral Cancer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Oral Cancer Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Oral Cancer Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Oral Cancer Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Oral Cancer Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Oral Cancer Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Oral Cancer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Oral Cancer Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Oral Cancer Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Oral Cancer Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oral Cancer Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Oral Cancer Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Oral Cancer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Oral Cancer Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Oral Cancer Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Oral Cancer Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Oral Cancer Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Oral Cancer Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Oral Cancer Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Oral Cancer Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Oral Cancer Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Oral Cancer Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oral Cancer Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Oral Cancer Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Plc Company Details
Table 62. AstraZeneca Plc Business Overview
Table 63. AstraZeneca Plc Oral Cancer Therapeutic Product
Table 64. AstraZeneca Plc Revenue in Oral Cancer Therapeutic Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Plc Recent Development
Table 66. Bristol-Myers Squibb Co. Company Details
Table 67. Bristol-Myers Squibb Co. Business Overview
Table 68. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Product
Table 69. Bristol-Myers Squibb Co. Revenue in Oral Cancer Therapeutic Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Co. Recent Development
Table 71. Eli Lilly and Co. Company Details
Table 72. Eli Lilly and Co. Business Overview
Table 73. Eli Lilly and Co. Oral Cancer Therapeutic Product
Table 74. Eli Lilly and Co. Revenue in Oral Cancer Therapeutic Business (2016-2021) & (US$ Million)
Table 75. Eli Lilly and Co. Recent Development
Table 76. Endo International Plc Company Details
Table 77. Endo International Plc Business Overview
Table 78. Endo International Plc Oral Cancer Therapeutic Product
Table 79. Endo International Plc Revenue in Oral Cancer Therapeutic Business (2016-2021) & (US$ Million)
Table 80. Endo International Plc Recent Development
Table 81. F. Hoffmann-La Roche Ltd. Company Details
Table 82. F. Hoffmann-La Roche Ltd. Business Overview
Table 83. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Product
Table 84. F. Hoffmann-La Roche Ltd. Revenue in Oral Cancer Therapeutic Business (2016-2021) & (US$ Million)
Table 85. F. Hoffmann-La Roche Ltd. Recent Development
Table 86. Merck & Co., Inc. Company Details
Table 87. Merck & Co., Inc. Business Overview
Table 88. Merck & Co., Inc. Oral Cancer Therapeutic Product
Table 89. Merck & Co., Inc. Revenue in Oral Cancer Therapeutic Business (2016-2021) & (US$ Million)
Table 90. Merck & Co., Inc. Recent Development
Table 91. Mylan NV Company Details
Table 92. Mylan NV Business Overview
Table 93. Mylan NV Oral Cancer Therapeutic Product
Table 94. Mylan NV Revenue in Oral Cancer Therapeutic Business (2016-2021) & (US$ Million)
Table 95. Mylan NV Recent Development
Table 96. Pfizer Inc. Company Details
Table 97. Pfizer Inc. Business Overview
Table 98. Pfizer Inc. Revenue in Oral Cancer Therapeutic Business (2016-2021) & (US$ Million)
Table 99. Pfizer Inc. Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Oral Cancer Therapeutic Product
Table 103. Sanofi Revenue in Oral Cancer Therapeutic Business (2016-2021) & (US$ Million)
Table 104. Sanofi Recent Development
Table 105. Teva Pharmaceutical Industries Ltd. Company Details
Table 106. Teva Pharmaceutical Industries Ltd. Business Overview
Table 107. Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Product
Table 108. Teva Pharmaceutical Industries Ltd. Revenue in Oral Cancer Therapeutic Business (2016-2021) & (US$ Million)
Table 109. Teva Pharmaceutical Industries Ltd. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Cancer Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Targeted Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Global Oral Cancer Therapeutic Market Share by Application: 2020 VS 2027
Figure 5. Floor of Mouth Cancer Case Studies
Figure 6. Gum Cancer Case Studies
Figure 7. Hard Palate Cancer Case Studies
Figure 8. Inner Cheek Cancer (Buccal Mucosa Cancer) Case Studies
Figure 9. Lip Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Oral Cancer Therapeutic Report Years Considered
Figure 12. Global Oral Cancer Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Oral Cancer Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Oral Cancer Therapeutic Market Share by Regions: 2020 VS 2027
Figure 15. Global Oral Cancer Therapeutic Market Share by Regions (2022-2027)
Figure 16. Global Oral Cancer Therapeutic Market Share by Players in 2020
Figure 17. Global Top Oral Cancer Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Cancer Therapeutic as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Oral Cancer Therapeutic Revenue in 2020
Figure 19. Global Oral Cancer Therapeutic Revenue Market Share by Type (2016-2021)
Figure 20. Global Oral Cancer Therapeutic Revenue Market Share by Type (2022-2027)
Figure 21. North America Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Oral Cancer Therapeutic Market Share by Type (2016-2027)
Figure 23. North America Oral Cancer Therapeutic Market Share by Application (2016-2027)
Figure 24. North America Oral Cancer Therapeutic Market Share by Country (2016-2027)
Figure 25. United States Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Oral Cancer Therapeutic Market Share by Type (2016-2027)
Figure 29. Europe Oral Cancer Therapeutic Market Share by Application (2016-2027)
Figure 30. Europe Oral Cancer Therapeutic Market Share by Country (2016-2027)
Figure 31. Germany Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Oral Cancer Therapeutic Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Oral Cancer Therapeutic Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Oral Cancer Therapeutic Market Share by Region (2016-2027)
Figure 41. China Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Oral Cancer Therapeutic Market Share by Type (2016-2027)
Figure 49. Latin America Oral Cancer Therapeutic Market Share by Application (2016-2027)
Figure 50. Latin America Oral Cancer Therapeutic Market Share by Country (2016-2027)
Figure 51. Mexico Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Oral Cancer Therapeutic Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Oral Cancer Therapeutic Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Oral Cancer Therapeutic Market Share by Country (2016-2027)
Figure 57. Turkey Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Oral Cancer Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AstraZeneca Plc Revenue Growth Rate in Oral Cancer Therapeutic Business (2016-2021)
Figure 61. Bristol-Myers Squibb Co. Revenue Growth Rate in Oral Cancer Therapeutic Business (2016-2021)
Figure 62. Eli Lilly and Co. Revenue Growth Rate in Oral Cancer Therapeutic Business (2016-2021)
Figure 63. Endo International Plc Revenue Growth Rate in Oral Cancer Therapeutic Business (2016-2021)
Figure 64. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Oral Cancer Therapeutic Business (2016-2021)
Figure 65. Merck & Co., Inc. Revenue Growth Rate in Oral Cancer Therapeutic Business (2016-2021)
Figure 66. Mylan NV Revenue Growth Rate in Oral Cancer Therapeutic Business (2016-2021)
Figure 67. Pfizer Inc. Revenue Growth Rate in Oral Cancer Therapeutic Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Oral Cancer Therapeutic Business (2016-2021)
Figure 69. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Oral Cancer Therapeutic Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の口腔がん治療市場規模・現状・予測（2021年-2027年） Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring a…- 世界の乳がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Therapeutic Market The global Breast Cancer Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の乳がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Therapeutic Market The global Breast Cancer Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の小分子標的がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Cancer Therapy Market The global Small Molecule Targeted Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…